KEGG   COMPOUND: C15894
Entry
C15894                      Compound                               

Name
Exendin-4
Sequence
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser
Ser Gly Ala Pro Pro Pro Ser-NH2
  Organism
  Type
Peptide
Remark
Same as: D04121
Brite
Target-based classification of compounds [BR:br08010]
 G Protein-coupled receptors
  Secretin family
   Glucagon
    glucagon-like peptide 1 receptor
     C15894  Exendin-4
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A10 DRUGS USED IN DIABETES
   A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
    A10BJ Glucagon-like peptide-1 receptor (GLP-1) analogues
     A10BJ01 Exenatide
      D04121  Exenatide (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
 Blood Glucose Regulators
  Antidiabetic Agents
   GLP-1 Receptor Agonist
    Exenatide
     D04121  Exenatide (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  24  Hormones
   249  Miscellaneous
    2499  Others
     D04121  Exenatide (JAN/USAN/INN)
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Secretin receptor family
   Glucagon
    GLP1R
     D04121  Exenatide (JAN/USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D04121
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D04121
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D04121
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D04121
Other DBs
PubChem: 47205214
ChEBI: 64073
NIKKAJI: J2.626.310G

» Japanese version

DBGET integrated database retrieval system